Leadership
Leadership Team Comprises Expertise Necessary to Develop Products & Company
Christopher Marshall PhD, President & CEO
Founded three biotechs, is an inventor and former strategy consultant.
Dirk Pleimes, MD, CMO
Founded four biotechs and worked in clinical development in large pharma. Expert in respiratory-inflammatory disease.
Mark Yondola, PhD, CSO
Established Calder’s bioprocess technology. Expert in vaccine design, protein chemistry and virology.
Susan Stella, MBA, Interim COO
Expert strategist with emerging tech & life science companies as well as investors.
Scientific Advisory Board
Barry Buckland, PhD
Merck Vaccines, VP Manufacturing for 16 years. Manufactured a large number of approved vaccine products.
Florian Schödel, MD
Merck Vaccines, VP Clinical Research for 8 years. Directed clinical studies for licensure of multiple approved vaccines.
Jason S. McLellan, PhD
Univ. of Texas. Pre-eminent in vaccine design. Most Covid-19 vaccines programs based on Jason’s 2P-design.
Alexander Hoffmann, PhD
UCLA. Pre-eminent in the field of innate immunity (adjuvants); Director, Instit. for Quant. & Computational Biosciences.
Key Personnel
Devarshi Brahmbhatt, MS
Expert in downstream process development.
Sonal Gidwani, MS
Expert in crosslinking chemistry and controls; analytical development.
Experts-In-Residence
Claudio Bertuccioli, PhD
Advising on financing strategies. Biotech VC for 15 years.
Heidi Agostini, PhD
Consulting on govt. funding strategies. Obtained & executed $200M-$7B BARDA/DoD/NIH contracts.
James E. Hough, JD
Consulting on communications and strategy; partner at Morrison & Foerster LLP for 25+ years
Peter Alff
Advising on financing and development strategies. Biotech VC, cofounder and former Dir. Strategic Initiatives at Calder